97296 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY
#5102Binding member which binds to both Lewis-and Lewis-haptens, and its use for treating cancer
#5103ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF
#5104Methods of ameliorating inflammatory disease using an uPA antagonist
#5105Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor
#5106Monoclonal antibody to CD166 and method for production thereof
#5107Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking Agents
#5108CLN248 Antibody Compositions and Methods of Use
#5109Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
#5110Antibodies to oncostatin M receptor
#5111Anti-VEGF monoclonal antibody
#5112HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#5113Multivalent immunoglobulin-based bioactive assemblies
#5114Anti-IGF-IR antibodies and uses thereof
#5115Enhancing the circulating half-life of antibody-based fusion proteins
#5116CD30 Ligand
#5117Substance specific to human PD-1
#5118Recombinant production of mixtures of antibodies
#5119Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
#5120INHIBITORS OF T-DARPP FOR USE IN COMBINATION ANTI-CANCER THERAPIES
#5121Antibodies that bind to EphA2 and methods of use thereof
#5122Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency
#5123Method for treating multiple myeloma
#5124Human GM-CSF antibodies
#5125ANTI-NOTCH1 NRR ANTIBODIES AND METHODS USING SAME
#5126ANTIBODY DESIGNATED BARB3, BARB3 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME
#5127COMBINATION OF HGF INHIBITOR AND EGF INHIBITOR TO TREAT CANCER
#5128NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#5129COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS
#5130Therapeutic compositions and methods
#5131Carbohydrate content of CTLA4 molecules
#5132Nanobodies and Polypeptides Against EGFR and IGF-IR
#5133Therapeutic use of anti-CS1 antibodies
#5134Inhibition of macrophage-stimulating protein receptor (ron)
#5135Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
#5136Compositions and methods for the diagnosis and treatment of tumor
#5137Anti-IL-6 antibody nucleic acid molecules and methods
#5138Therapeutic use of anti-CS1 antibodies
#5139THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
#5140NOVEL RABBIT ANTIBODY HUMANIZATION METHODS AND HUMANIZED RABBIT ANTIBODIES
#5141Hepatitis C virus inhibitors
#5142Anti-TYRP1 antibodies
#5143Elastase inhibitor and acute leukemia
#5144Anti-tissue factor antibodies and compositions
#5145Antibodies as T cell receptor mimics, methods of production and uses thereof
#5146THERAPEUTIC ANTI-HER2 ANTIBODY FUSION POLYPEPTIDES
#5147Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
#5148Polypeptides and Antibodies
#5149Antibodies That Immunospecifically Bind to TRAIL Receptors
#5150Zalpha11 cytokine receptors
#5151Metadherin polypeptides, encoding nucleic acids and methods of use
#5152Caspase-cleavage anti-keratin antibodies for detection of apoptosis
#5153THERAPEUTIC AGENTS FOR ALZHEIMER'S DISEASE AND CANCER
#5154COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS
#5155Anti MIF Antibodies
#5156COMBINATORIAL THERAPY
#5157ANTIBODIES AND USES THEREOF
#5158Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
#5159Anti-EphrinB2 antibodies and methods using same
#5160Antibodies and related molecules that bind to 161P2F10B proteins
#5161B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES
#5162Anti-IL13 antibodies and uses thereof
#5163Method for identifying diabetic patients at increased risk for pathological complications
#5164Method for screening for an anti-CD4 antibody suitable for use in immunotherapy
#5165Humanized anti-CD4 antibody with immunosuppressive properties
#5166Antibodies that bind OV064 and methods of use therefor
#5167SUPERANTIBODY SYNTHESIS AND USE IN DETECTION, PREVENTION AND TREATMENT OF DISEASE
#5168Cytotoxicity mediation of cells evidencing surface expression of CD44
#5169HUMANIZED ANTI CD20 MONOCLONAL ANTIBODY
#5170Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same
#517188kDa tumorigenic growth factor and antagonists
#5172PM-2 ANTIBODIES, FUNCTIONAL FRAGMENTS AND METHODS FOR TREATING METASTASIS
#5173Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
#5174Anti-claudin-4 antibody
#5175Antibodies and related molecules that bind to PSCA proteins
#5176Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
#5177Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA
#5178Methods of treating viral infections using IL-21
#5179ANTI-PSGL-1 ANTIBODIES
#5180Anti-CD20 monoclonal antibody
#5181METHODS OF PRODUCING ANTIBODIES TO ZALPHA11 CYTOKINE RECEPTORS
#5182B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
#5183Methods and compositions for treating diseases targeting CDCP1
#5184Non-functional P2Xreceptor
#5185Nucleolin-mediated cancer diagnostics and therapy
#5186Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
#5187Anti-human IL-21 monoclonal antibodies
#5188Angiopoietin-2 Specific Binding Agents
#5189Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies
#5190METHODS OF TREATING INFECTIONS USING IL-21
#5191CANCEROUS DISEASE MODIFYING ANTIBODIES
#5192CANCEROUS DISEASE MODIFYING ANTIBODIES
#5193Apo-2 ligand
#5194METHODS FOR INHIBITING AN IMMUNE RESPONSE BY BLOCKING THE GP39/CD40 AND CTLA4/CD28/B7 PATHWAYS AND COMPOSITIONS FOR USE THEREWITH
#5195Anti-αβantibodies
#5196Antibodies and related molecules that bind to PSCA proteins
#5197Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist
#5198Humanized anti-CD40 antibodies and their methods of use
#5199Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors
#5200METHODS OF USING PHHLA2 TO CO-STIMULATE T-CELLS
#5201YKL-40 monoclonal authority
#5202TREATMENT OF B-CELL MALIGNANCIES
#5203Compositions and methods of use for antibodies of c-Met
#5204Human Antibodies That Bind Human IL-12 And Methods For Producing
#5205NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#5206Anti-VEGF antibody compositions and methods
#5207Methods and agents for improving targeting of CD138 expressing tumor cells
#5208VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#5209Monoclonal antibodies against claudin-18 for treatment of cancer
#5210High affinity antibodies against HMGB1 and methods of use thereof
#5211Method for Preparing Antibody Conjugates
#5212Treatment of tumors using specific anti-L1 antibody
#5213ANTI-IGF-I RECEPTOR ANTIBODY
#5214Engineered anti-IL-23 antibodies
#5215COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#5216Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same
#5217Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#5218Type I interferon blocking agents for prevention and treatment of psoriasis
#5219Remedies for inflammatory bowel diseases
#5220IL-17A and IL-17F antagonists
#5221Immunoglobulin variants and uses thereof
#5222Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
#5223Polypeptide compounds for inhibiting angiogenesis and tumor growth
#5224Methods for treating disorders involving monocytes
#5225Anti-IGF-I receptor antibody
#5226Human C-FMS antigen binding proteins
#5227HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF
#5228Pharmaceutical composition for treating immune diseases
#5229POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#5230Human antibodies to human delta like ligand 4
#5231Preventive/Remedy for Cancer
#5232PROPHYLACTIC/THERAPEUTIC AGENT FOR CANCER
#5233Anti-VEGF antibodies
#5234Tweak receptor
#5235Compositions and Methods for the Diagnosis and Treatment of Tumor
#5236POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
#5237Anti-CD26 antibodies and methods of use thereof
#5238CD-20 specific antibodies and methods of employing same
#5239Antibodies that bind specifically to human RON protein
#5240TRAIL receptor-binding agents and uses of the same
#5241Preventives/Remedies for Cancer
#5242Methods and compositions for inhibiting CD32B expressing cells
#5243Compositions and methods for binding lysophosphatidic acid
#5244Neoplasm-specific polypeptides and their uses
#5245CEACAM8-related method for treating autoimmune diseases
#5246Anti-CD40 antibodies capable of blocking B-cell activation
#5247Anti-CD20 antibodies and methods of use
#5248IDENTIFICATION OF UNIQUE BINDING INTERACTIONS BETWEEN CERTAIN ANTIBODIES AND THE HUMAN B7.1 AND B7.2 CO-STIMULATORY ANTIGENS
#5249Human antibody molecules for IL-13
#5250Antibodies
#5251TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF
#5252Antibodies Against Cancer
#5253ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
#5254CCR3 inhibition for ocular angiogenesis and macular degeneration
#5255Methods for use in human-adapting monoclonal antibodies
#5256Purified antibody to the extracellular domain of NKp44L
#5257Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody
#5258Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
#5259Stabilizer for protein preparation comprising meglumine and use thereof
#5260METHODS AND COMPOSITIONS FOR INHIBITION OF METASTASIS
#5261Antibodies against PDGFRa
#5262Calicheamicin conjugates
#5263PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
#5264CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
#5265Monoclonal Antibodies to Hepatocyte Growth Factor
#5266Humanized anti-CD4 antibody with immunosuppressive properties
#5267ANTIBODY AND ANTIBODY FRAGMENTS FOR INHIBITING THE GROWTH OF TUMORS
#5268CA6 antigen-specific cytotoxic conjugate and methods of using the same
#5269Methods for attenuating virus strains for diagnostic and therapeutic uses
#5270PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease
#5271IMMUNOGENIC COMPOSITIONS FOR INDUCTION OF ANTI-TUMOR IMMUNITY
#5272CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
#5273Anti-IGF-1R Antibodies and Uses Thereof
#5274Use of an antibody that binds human tumor necrosis factor receptor-like 2
#5275TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES
#5276ICAM-1 binding antibodies
#5277Compositions and methods for the diagnosis and treatment of tumor
#5278Anti-Notch1 NRR antibodies
#5279METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES
#5280METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE DISEASE
#5281METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE DISEASE
#5282Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells
#5283Antibodies against CD38 for treatment of multiple myeloma
#5284KIR-binding agents and methods of use thereof
#5285AUTOPHILIC ANTIBODIES
#5286Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
#5287Therapeutic use of anti-tweak receptor antibodies
#5288METHODS FOR DECREASING IMMUNE RESPONSE AND TREATING IMMUNE CONDITIONS
#5289HUMAN THERAPIES USING CHIMERIC AGONISTIC ANTI-HUMAN CD40 ANTIBODY
#5290ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
#5291Product
#5292ErbB4 antagonists
#5293Treatment And Prophylaxis With 4-1BB-Binding Agents
#5294Cytotoxicity mediation of cells evidencing surface expression of CD9
#5295Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
#5296ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR
#5297ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS
#5298Carbonic anhydrase IX (G250) anitbodies
#5299Compositions and methods for the therapy and diagnosis of lung cancer
#5300ENHANCEMENT OF ANTIBODY-MEDIATED IMMUNE RESPONSES
#5301Specific binding agents of human angiopoietin-2
#5302MONOCLONAL ANTIBODY, GENE ENCODING THE ANTIBODY, HYBRIDOMA, PHARMACEUTICAL COMPOSITION, AND DIAGNOSTIC REAGENT
#5303Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#5304PDGFRβ-specific antibodies
#5305Compositions and methods for the treatment of tumor of hematopoietic origin
#5306Methods of treating cancer by administering antibodies to CD200
#5307Anti-GM-CSF antibodies and uses therefor
#5308Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
#5309Stabilized polypeptide compositions
#5310Prophylactic/Therapeutic Agent for Cancer
#5311Optimized Fc variants
#5312Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer
#5313Methods and compositions for treating diseases targeting MABA1
#5314NEOPLASM-SPECIFIC POLYPEPTIDES AND THEIR USES
#5315Human monoclonal antibodies to CD70
#5316Antagonists specific for denatured collagen and methods of using same
#5317Anti-CD79B antibodies and immunoconjugates and methods of use
#5318Antibodies directed to the mammalian EAG1 ion channel protein
#5319Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ)
#5320Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
#5321Combinations of antibodies selective for DR5 and other therapeutic agents
#5322Novel Pharmaceuticals That Use Anti-HLA Antibodies
#5323ANTIBODIES AND RELATED MOLECULES THAT BIND TO 161P2F10B PROTEINS
#5324Methods for diagnosing renal disorders
#5325Antibodies to the Human Prolactin Receptor
#5326Human antibodies to human delta like ligand 4
#5327Methods for interfering with rank signaling
#5328ANTIBODIES TO HUMAN SOMATOSTATIN RECEPTOR AND METHODS OF USE
#5329Compositions and methods for the treatment of respiratory disorders
#5330Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies
#5331Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies
#5332Compositions and Methods of Treating Tumors
#5333Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
#5334ANTIBODY VARIANTS
#5335Apoptotic anti-IgE antibodies
#5336Antigen binding molecules with increased Fc receptor binding affinity and effector function
#5337Receptor based antagonists and methods of making and using
#5338Prostate cancer specific internalizing human antibodies
#5339Cytotoxicity mediation of cells evidencing surface expression of CD44
#5340Methods for inhibiting the growth of cancer cells expressing PSCA
#5341Therapeutic uses of factors which inhibit or neutralize MIF activity
#5342Human monoclonal antibody binding to hGM-CSF and its antigen binding portion
#5343RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF
#5344Anti-IL2 antibodies
#5345Compositions and methods for inhibiting growth of smad4-deficient cancers
#5346Anti-IL-6 antibodies, compositions, methods and uses
#5347Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
#5348Autocrine growth factor receptor antibodies and methods
#5349Vascular endothelial cell growth factor antagonists and uses thereof
#5350Antibodies against PD-1 and uses therefor
#5351Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
#5352Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor
#5353KIR-binding agents and methods of use thereof
#5354HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#5355Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
#5356PROTECTIVE STAPHYLOCOCCUS AUREUS VACCINE BASED ON CELL WALL-ASSOCIATED PROTEINS
#5357TREATMENT OF CHEMOTHERAPY- OR RADIOTHERAPY-RESISTANT TUMORS
#5358Antibodies to CD83
#5359MULTIVALENT ANTIBODIES AND USES THEREFOR
#5360Vascular endothelial cell growth factor antagonists and uses thereof
#5361Antibodies to GM-CSF
#5362Therapeutic Uses of A3 Adenosine Receptor Antibodies
#5363PRLR-specific antibody and uses thereof
#5364CANINE IgG NUCLEIC ACID MOLECULES
#5365EphA3 antibodies for the treatment of solid tumors
#5366Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)
#5367B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
#5368Means for the diagnosis and therapy of CTCL
#5369Anti-EGFR antibodies
#5370Cell Death-Inducing Agents
#5371Mesothelioma therapeutic agent
#5372ANTIBODIES AND USES THEREOF
#5373Cytotoxicity mediation of cells evidencing surface expression of CD44
#5374Compositions and Methods for Modulating DNA Repair
#5375Anti-angiogenic targets for cancer therapy
#5376Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
#5377Methods for Treating Cancer Using Agents That Inhibit Wnt16 Signaling
#5378Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
#5379OPTIMIZED ANTIBODIES THAT TARGET CD19
#5380Method of treating cancer comprising a VEGF-B antagonist
#5381Methods of treating arthritic conditions with antibodies to M-CSF
#5382Optimized CD5 antibodies and methods of using the same
#5383Antagonist anti-CD40 antibodies
#5384TIE1-BINDING LIGANDS
#5385VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
#5386Anti-IL-20 antibodies and binding partners and methods of using in inflammation
#5387Antibody-Mediated Induction of Tumor Cell Death
#5388REMEDY FOR MAMMARY CANCER
#5389Soluble IL-17RA/RC fusion proteins
#5390Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
#5391Transgenic mammals having human IG loci including plural Vand Vregions and antibodies produced therefrom
#5392Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
#5393Human DR4 antibodies and uses thereof
#5394COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#5395Compositions and methods for inhibiting squamous cell carcinoma
#5396Human monoclonal antibodies to CTLA-4
#5397COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY LUNG DISEASE
#5398Human monoclonal antibodies to CTLA-4
#5399ANTI-IL-20 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
#5400Trefoil Factor 3 (Tff3) as a Target for Anti-Cancer Therapy